Rocket


Overview
Financials
News + Filings
IR Vault
Key Docs
Charts
Ownership
Insiders


All
All (ex-4s)
10-K
10-Q
8-K
3,4,5
Proxy
Prospectus
Other
Tags
Quarterly results
CC transcript
Appointed director
PharMerica CORP (PMC) Create: Alert

All | News | Filings
Date FiledTypeDescription
02/13/2018 SC 13G/A Form SC 13G/A - Statement of acquisition of beneficial ownership by individuals: [Amend]
02/09/2018 SC 13G/A Form SC 13G/A - Statement of acquisition of beneficial ownership by individuals: [Amend]
12/18/2017 15-12B Form 15-12B - Securities registration termination [Section 12(b)]:
12/08/2017 25-NSE Form 25-NSE - Notification filed by national security exchange to report the removal from listing and registration of matured, redeemed or retired securities:
12/07/2017 S-8 POS Form S-8 POS - Securities to be offered to employees in employee benefit plans, post-effective amendments:
12/07/2017 S-8 POS Form S-8 POS - Securities to be offered to employees in employee benefit plans, post-effective amendments:
12/07/2017 8-K Resignation/termination of a director
Docs: "Amended and Restated Certificate of Incorporation of PharMerica Corporation",
"Amended and Restated Bylaws of PharMerica Corporation",
"KKR Completes Acquisition of PharMerica"
12/07/2017 S-8 POS Form S-8 POS - Securities to be offered to employees in employee benefit plans, post-effective amendments:
11/09/2017 8-K Quarterly results
Docs: "LOUISVILLE, Ky. (November 9, 2017"
11/09/2017 BW PharMerica Reports Third Quarter 2017 Results
11/09/2017 10-Q Quarterly Report for the period ended September 30, 2017
11/09/2017 8-K Submission of Matters to a Vote of Security Holders, Other Events, Financial Statements and Exhibits
Docs: "PharMerica Announces Approval of Merger by Stockholders"
10/27/2017 8-K Quarterly results
10/27/2017 DEFA14A Form DEFA14A - Additional definitive proxy soliciting materials and Rule 14(a)(12) material:
10/03/2017 DEFM14A Form DEFM14A - Definitive proxy statement relating to merger or acquisition:
09/06/2017 PREM14A Form PREM14A - Preliminary proxy statements relating to merger or acquisition:
08/28/2017 8-K Quarterly results
08/28/2017 DEFA14A Form DEFA14A - Additional definitive proxy soliciting materials and Rule 14(a)(12) material:
08/02/2017 8-K Entry into a Material Definitive Agreement, Financial Statements and Exhibits
Docs: "Agreement and Plan of Merger among PharMerica Corporation, Phoenix Parent Holdings Inc. and Phoenix Merger Sub Inc.",
"Antitrust Support Side Letter among PharMerica Corporation, KKR Americas Fund XII L.P. and Walgreens Boots Alliance, Inc."
08/02/2017 DEFA14A Form DEFA14A - Additional definitive proxy soliciting materials and Rule 14(a)(12) material:
08/02/2017 DEFA14A Form DEFA14A - Additional definitive proxy soliciting materials and Rule 14(a)(12) material:
08/02/2017 8-K Quarterly results
08/02/2017 10-Q Quarterly Report for the period ended June 30, 2017
08/02/2017 8-K Quarterly results
08/02/2017 DEFA14A Form DEFA14A - Additional definitive proxy soliciting materials and Rule 14(a)(12) material:
08/02/2017 BW PharMerica Reports Second Quarter 2017 Results
07/27/2017 GN First Choice Appoints New CFO to Help Lead Company Through Next Phase of Strategic Execution
07/20/2017 BW PharMerica Corporation Announces Second Quarter 2017 Earnings Call and Webcast
06/19/2017 8-K Form 8-K - Current report
05/10/2017 10-Q Quarterly Report for the period ended March 31, 2017
05/10/2017 8-K Form 8-K - Current report
05/10/2017 BW PharMerica Reports First Quarter 2017 Results
05/01/2017 DEF 14A Form DEF 14A - Other definitive proxy statements
04/21/2017 8-K Form 8-K - Current report
  Next >>

Rocket Data Systems, Inc. © 2019 | Contact Us | Data Disclaimer | Terms of Use | Privacy